Notice Number: NOT-AI-19-019

Key Dates
Release Date: December 20, 2018

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Purpose

The purpose of this Notice is to alert potential applicants to a change in the expiration date for Funding Opportunity Announcement (FOA) PA-17-279 "HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01)”. This FOA will expire on January 8, 2019 (earlier than previously published); the last date that NIAID, NCI and NIAAA will accept applications for PA-17-279 is January 7, 2019. After January 7, 2019, applicants may apply to the new NIAID FOA, PAS-19-097 “Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)”.

Part 1: Overview Information

Key Dates

Current Date:

Expiration Date: May 8, 2020

Revised Date:

Expiration Date: January 8, 2019

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Christine Chiou, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-292-4181
Email: [email protected]

Rebecca Liddell Huppi, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-496-4995
Email: [email protected]

Vaurice Starks (for epidemiological studies)
National Cancer Institute (NCI)
Telephone: 301-624-1299
Email: [email protected]

H. Joe Wang, Ph.D. (for basic biological-immunologic studies and tissue injury)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-451-0747
Email: [email protected]

Kendall Bryant, Ph.D. (for epidemiological and clinical studies)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-402-9389
Email: [email protected]